Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, FDA approval and commercial launch for a full portfolio of pacing, defibrillation and left ventricular leads.

U.S. Ambassador to Nigeria Terence McCulley on Tuesday in Abuja, Nigeria, launched a five-year, $224 million USAID program, titled Strengthening Integrated Delivery of HIV/AIDS Services (SIDHAS), that aims to "increase access to high-quality comprehensive HIV/AIDS and tuberculosis prevention, treatment, care and related services through improved efficiencies in service delivery," the ...

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, FDA approval and commercial launch of the PARADYM RF family of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT-D) ...

Energetiq Technology, Inc., a developer and manufacturer of ultrahigh-brightness, broadband light sources for advanced technology applications, today introduced a new light source to its established line of LDLS Laser-Driven Light Sources for use in radiometric calibration.

The National Council on Patient Information and Education (NCPIE) today launched three customized, online educational modules to promote safe use of acetaminophen products.

Medical Vision AB today announced the launch of their new technology Double® Pump RF, an arthroscopy pump that adjusts flow and pressure automatically when a Shaver or an RF system is in use. Suction is simultaneously directed through the Shaver or RF handpiece to improve the functionality of these systems. ...

A post on the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog describes an event to launch a recent report from GHTC and Policy Cures on "data on U.S. investments over the past 10 years in global health research and development (R&D)."

EKOS Corporation today announced the launch of two more landmark clinical studies named SEATTLE I & II, intended to further establish the safety and efficacy of its unique, ultrasound-accelerated thrombolysis in treating patients with life-threatening pulmonary embolism.

(Harvard School of Public Health) The Obesity Prevention Source website aims to give the public, health professionals, public health practitioners, business and community leaders, and policymakers quick and easy access to science-based information about obesity's causes, its dire consequences, and what can and must be done to turn back obesity's ...

BTG International Inc., the specialist healthcare company today announces the launch of Voraxaze (glucarpidase) in the US. Voraxaze is indicated for the treatment of toxic plasma methotrexate concentrations (>1 micromole per liter) in patients with delayed methotrexate clearance due to impaired renal function.

IRIDEX Corporation today announced the launch of a new non-invasive, in-office glaucoma procedure based on its proprietary MicroPulse technology. The new glaucoma therapy, a tissue-sparing, repeatable therapy called MicroPulse Laser Trabeculoplasty (MLT), was introduced by IRIDEX at the recent American Society of Cataract and Refractive Surgery (ASCRS).

Sophia Antipolis, France, 19 April 2012: The European Society of Cardiology (ESC) announced today the launch of the European Heart Journal: Acute Cardiovascular Care , the organisation's official journal of the ESC Working Group on Acute Cardiac Care. "This new journal will be an important ...